ANI Pharmaceuticals, Inc. is a diversified bio-pharmaceutical company serving patients in need by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceutical products.
ANI Pharmaceuticals Announces Results from NEW DAY Clinical Trial of ILUVIENĀ® for Use in Patients with Diabetic Macular Edema (DME)
2025-07-23
ANI Pharmaceuticals to Participate at Leerink Partners Therapeutics Forum: I&I and Metabolism on July 8th
2025-07-02
$67.48
+0.71 ( 1.06% )
Pricing delayed by 20 minutes
Last updated
2025-07-25 16:00:00